Key facts
- Notable investors include JITO Incubation & Innovation Foundation, Bangalore Bioinnovation Centre, Centre for Cellular And Molecular Platforms, QB3.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Aten Porus Lifesciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Aten Porus Lifesciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aten Porus Lifesciences
Operator of an innovation-driven company intended to develop therapeutics for diseases with a high unmet medical need. The company's platform utilizes chemistry-oriented tools and drug discovery technologies to design innovative medicines for a wide range of diseases, enabling the medical field to develop treatments for illnesses that currently have no effective solutions.
- Sector
- Healthcare
- HQ
- Bangalore, India
- Founded
- 2013
- Employees
- 23
- Website
- atenporus.com/
- Ownership
- Privately Held (backing)
Aten Porus Lifesciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aten Porus Lifesciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aten Porus Lifesciences in its N-PORT filings yet. We sweep new filings monthly.